Field Safety Corrective Action
Action taken to reduce a risk of serious deterioration in health associated with a device.
Definition
An FSCA is any action taken by a manufacturer to reduce the risk of a serious incident in relation to a device already placed on the market, including device modifications, exchange, return, destruction, or advice to users (FSN).What this means in practice
FSCAs are reported to Competent Authorities in the EU and may correspond to FDA recalls, depending on classification.Examples
- A manufacturer issues an FSCA to update the software of an infusion pump to correct a bug that could lead to incorrect dose delivery.
- An FSCA is initiated to replace a specific component in an implantable device after reports of premature degradation, potentially affecting patient safety.
- A Field Safety Notice is distributed to advise healthcare professionals on a revised cleaning protocol for a reusable surgical instrument to prevent cross-contamination.
- •A common pitfall is failing to promptly initiate an FSCA when new risk information emerges, potentially leading to more severe patient harm and regulatory penalties.
- •Manufacturers sometimes incorrectly assume that minor product updates do not require an FSCA, even if they address a potential safety concern.
- •Not all product changes or customer communications qualify as an FSCA, leading to confusion about reporting obligations.
- •Failure to adequately communicate the FSCA to all affected parties, including users and distributors, can undermine its effectiveness.
- •Inadequate documentation of the FSCA process and its outcomes can lead to compliance issues during audits.
Frequently asked questions
Cross-references
See also
Closely related context worth reading.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsEU MDR Essentials
· From this learning pathPeriodic EU MDR/IVDR report summarizing post-market surveillance findings.
Mandatory European conformity mark for medical devices placed on the EU market.
Regulation (EU) 2017/746 governing in vitro diagnostic medical devices in the EU.
European Database on Medical Devices.
Post-Market Mastery
· From this learning pathFDA mechanism for receiving reports of device-related deaths, serious injuries, and malfunctions.
Activities to monitor device safety and performance after market release.
Process for receiving, evaluating, and responding to device complaints.
Systematic process to investigate and resolve quality issues and prevent recurrence.
IVDR Essentials
· From this learning pathEU-designated organization that assesses conformity of medical devices under MDR and IVDR.
IVDR equivalent of PMCF - ongoing collection of performance data for in vitro diagnostics.
Periodic Safety Update Report obligations for IVDs under EU IVDR Article 81.
EU MDR document that defines the scope, methods, and acceptance criteria for the clinical evaluation that will be reported in the Clinical Evaluation Report (CER).
Mentioned in recent activity
10 entriesLatest in MedTech
Recent regulatory actions, publications, and trials matched to this term. Updated daily.
-
Recall2026-03-25DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff Maculorhexis Forceps, Model/Catalog Number: DVF4019-25-S
Class II · Katalyst Surgical, LLC
-
Recall2026-03-25DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff Serrated Forceps, Model/Catalog Number: DVF4016-25-S
Class II · Katalyst Surgical, LLC
-
Recall2026-03-25DEX Ophthalmic Tissue Forceps, 25ga DEX Stiff End Grasping Forceps, Model/Catalog Number: DVF4022-25-S
Class II · Katalyst Surgical, LLC
Primary references
3 sources- 1
MDCG Vigilance GuidanceVerifiedMDCGhealth.ec.europa.eu
- 2
FDA MAUDE DatabaseVerifiedFDAaccessdata.fda.gov
- 3
FDA Recalls - Medical DevicesVerifiedFDAfda.gov
Inline markers like [1] jump to the matching reference above.